Dr Kevin Woodward from McMaster University meets with Dr Roman Jaeschke to discuss the resurgence of mpox, different clades of the virus, current treatments, and vaccination strategies.
Is transthoracic echocardiography sufficient to exclude infective endocarditis in a patient with FUO and negative blood culture results? Can a patient with infective endocarditis have normal echocardiography results? With Dr Margarita Brida.
With the current progress of medicine, can we expect that the use of insulin in people with type 2 diabetes will soon pass into history and the only injection therapy will involve effective drugs from the glucagon-like peptide-1 (GLP-1) receptor agonists, promoting significant weight loss?
What is the place of long-acting insulin analogues with higher than standard concentrations (200 IU/mL and 300 IU/mL) in the treatment of type 2 diabetes? In which patients should we expect the benefits to justify recommending the drug despite the higher cost to the patient?
How big a problem is the coexistence of chronic kidney disease (CKD) and obesity? In a person starting renal replacement therapy, is obesity or malnutrition a greater risk?
What is the current place of cannabidiol and other cannabinoids in the treatment of epilepsy? How often are OTC cannabinoid preparations used by patients with epilepsy in North America? How does it affect the clinical management of epilepsy?
What is the typical time between starting the ACEI treatment and the occurrence of cough? How long should we wait for suspected ACEI-induced cough to resolve?